In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform A seminar given on two occasions, this one targeted for the EUROPEAN time zone […]
In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform A seminar given on two occasion. This one targeted forthe US audience at 13:00 […]
SenzaGen is participating at The Society of Toxicology of Canada 50th Annual Symposium, Winter 2018 WHAT’S IN A NAM ? (NOVEL APPROACH METHODOLOGIES). BENEFITS, LIMITATIONS, TRANSLATION, COMMUNICATION. | DECEMBER 10 […]
SenzaGen is attending the Training and Knowledge-sharing Workshop - "Applying non-animal strategies for assessing skin sensitization" in Helsinki, Finland. The main objective of the workshop is to discuss how the information […]
SenzaGen will exhibit at Booth #3652 Share your knowledge at the largest toxicology meeting in the world and get the latest updates on the advances in toxicology by attending the SOT […]
Heading into its 30th edition in 2019, in-cosmetics Global is the leading event for personal care ingredients. The exhibition brings together personal care ingredients suppliers (exhibitors) with finished product manufacturers (visitors), each looking to […]
EUROPEAN TIMEZONE Are you curious about potential applications of genomics or machine learning? Have you ever wondered how the GARD test platform works? This presentation will provide a comprehensive explanation […]
AMERICAN TIMEZONE 2 am EDT Are you curious about potential applications of genomics or machine learning? Have you ever wondered how the GARD test platform works? This presentation will provide […]
Presentation by Dr. Andy Forreryd Session: Developing in vitro based alternatives to animal testing Date: 13 June Time: 14:00-15:30 Chair: Prof. Juliette Legler Speakers: Dr. Ivan Kopljar, Dr. Peter Racz, […]
GARD™air - An in vitro assay to test for respiratory sensitizers using genomic biomarkers and machine learning Presenter: Joshua Schmidt, SenzaGen Inc., USA Co-author: Andy Forreryd, SenzaGen AB, Lund, Sweden […]
